A healthcare company focused on providing a modern approach to Polycystic Ovary Syndrome (PCOS).

May Health

May Health, formerly AblaCare, is developing a modern approach to PCOS. 

May Health announced today their $25M Series B financing. These critical funds will support the companies Pivotal study, REBALANCE, and CE Mark. The team is grateful for the continued support of Sofinnova Partners, Antoine Papiernik and Anne Osdoit, and welcome our new investors, Trill Impact's Nina Rawal and Bita Sehat, PhD, and Bpifrance's, Jean-François Morin and Antoine Mérien.

If you're at ASRM this year, don't miss this opportunity to learn more about our ULTRA Trial results. 
#ASRM2023 #PCOS  #mayhealth

Thank YOU PCOS Challenge: The National Polycystic Ovary Syndrome Association - the work you are doing is so meaningful to so many people! We are honored to partner with you.

Great interview with Sasha Ottey of #PCOSChallenge!
#pcos #pcosawareness #womenshealth

COM:MAYHEALTH

May Health

Analysis Not Available